ArticleAmerican journal of clinical dermatology2023

Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy.

Eftychia Chatziioannou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.